Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Aug. 1, 2025, Mallinckrodt and Endo announced that they have completed their merger to create a global, scaled,…
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer
On Aug. 1, 2025, the Mayo Clinic announced it had treated the first person in the U.S. using…
Biotechnology | CMO | Medical Device | Medicine | Pharmaceutical | Vaccine
Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines
On Jul. 25, 2025, Simtra BioPharma announced the purchase from Cook Group of a 65-acre property (301 N….
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
Hikma Pharmaceuticals announces $1 Billion investment in U.S. Expansion
On Jun. 28, 2025, Hikma Pharmaceuticals USA announced it will invest $1 billion by 2030 to further expand…
Google DeepMind Announces AlphaGenome: AI for better understanding the genome
On Jun. 25, 2025, Google Deepmind introduce AlphaGenome, a new artificial intelligence (AI) tool that more comprehensively and…
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
Purdue Pharma $7.4 billion opioid settlement wins broad support from US states
On Jun. 16, 2025, Purdue Pharma has won support from the attorneys general of 55 U.S. states and…
Dr. Delese Mimi Darko Appointed Inaugural Director General of the African Medicines Agency (AMA)
On Jun. 4, 2025, the Conference of State Parties (CoSP) of the African Medicines Agency (AMA) announced the…
Artificial Intelligence | Biotechnology | Diagnostics | FDA | Medical Device | Pharmaceutical | Therapeutics | Vaccine | Women's Health
FDA Launches Agency-Wide AI Tool to Optimize Performance
On Jun. 2, 2025, the U.S. Food and Drug Administration (FDA) announces it has launched Elsa, a generative…
Lilly expands pain pipeline with acquisition of SiteOne Therapeutics for $1.0 billion in cash
On May 27, 2025, Eli Lilly and SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of…
Pharmaceutical giant looks to bring $5.9 billion facility to Houston
On May 21, 2025, pharmaceutical company Eli Lilly and Company is looking to build a $5.9 billion active…
Disease | FDA | Neurology | Pharmaceutical | Therapeutics
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
Kodak announces $20 million investment in Rochester manufacturing plant
On May 9, 2025, Kodak announced it was readying to open its new $20 million manufacturing facility at…
Biology | Chemistry | Environmental | EPA | FDA | Marine Science | Medicine | Pharmaceutical
Antibiotics from human use are contaminating rivers worldwide, study shows
On May 9, 2025, a McGill University led team of researchers announced a study that shows an estimated…
EMA Uses AI to Leverage the power of data for public and animal health
On May 7, 2025, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published…
Bristol Myers to invest $40 billion in the U.S. over 5 years
On May 5, 2025, Bristol Myers Squibb said it will invest $40 billion in the U.S. over the…
Merck Breaks Ground on $1 Billion Biologics Center in Wilmington, Delaware
On Apr. 29, 2025, Merck announced the start of construction for a $1 billion, 470,000 square-foot state-of-the-art biologics…
Merck to Acquire SpringWorks Therapeutics for $3.9 Billion
On Apr. 28, 2025, Merck and SpringWorks Therapeutics announced the companies have entered into a definitive agreement for…
Roche to invest $50 billion in pharmaceuticals and diagnostics in the U.S. over the next five years
On Apr. 22, 2025, Roche announced that it will invest USD $50 billion into the United States in…
Agriculture | Biotechnology | COVID-19 | Diagnostics | Energy | Environmental | EPA | FDA | Forestry | Genomics | HIV | Infectious Disease | Influenza | Measles | Nanotechnology | Neurology | NIH | Oncology | Pharmaceutical | Polio | Stem Cell | Therapeutics | USDA | Vaccine | Veterinary | Women's Health
Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
Novartis to expand US-based manufacturing and R&D footprint with investment of $23B over the next 5 years
On Apr. 10, 2025, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over…
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Measles | Medicine | Neurology | NIH | Oncology | Organ Transplant | Pharmaceutical | Plague | Polio | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
HHS starts layoffs of thousands of workers across its agencies
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
Merck buys rights to heart disease drug in latest China deal worth up to $2 billion
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
On Mar. 19, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
Mallinckrodt and Endo Combine in $6.7 billion Deal to Create Diversified Pharmaceuticals Leader
Mar. 13, 2025, Mallinckrodt and Endo,announced that they had entered into a definitive agreement to combine in a stock…
Biotechnology | Genomics | Infectious Disease | Medicine | Nanotechnology | Pharmaceutical | Vaccine
“Earth is a Rock, Let the DNA Mold me” rewritten hit Rock n’ Roll Song Celebrating ‘Science and Reason’ released
On Mar. 3, 2025, LifeScienceHistory.com: Where history is made daily announces the release of a rewritten hit rock…
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
Agriculture | Biotechnology | Infectious Disease | Influenza | Measles | Pharmaceutical | Polio | Therapeutics | Vaccine | Veterinary | WHO | Women's Health
U.S. announces withdrawal from the World Health Organization
On Jan. 20, 2025, the White House announced the United States will exit the World Health Organization (WHO)….